Rare diseases
Investigational molecules
Locations
Muellner Hauptstrasse 48, 5020 Salzburg, Austria
The sponsor is involved in clinical research for locally advanced and metastatic squamous cell carcinoma of the skin, with interest in immune checkpoint therapy and treatment strategies for advanced cutaneous malignancies.
These activities reflect a focus on solid tumor management in skin cancer, including disease control and response assessment in advanced dermatologic oncology.
Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH runs clinical trials in conditions such as Squamous cell carcinoma of skin, Erysipelas, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
